Pharmacists worried about impact of AMP rule
More than a quarter of pharmacists say they will be forced to close their pharmacies if CMS enacts a proposed rule to base reimbursement for Medicaid generic drugs on the average manufacturers price (AMP), according to an on-line poll at drugtopics.com. Another 25% of the 271 pharmacists who participated in the poll responded that they would push for higher dispensing fees in their state. Others responded that if the rule is enacted as it was proposed, it could force them to change how they participate in Medicaid, with 18% pledging that they would no longer participate in the program, 12% vowing they would switch patients from generic to brand drugs, and 11% suggesting they would stop dispensing generic drugs for Medicaid patients. Only 8% of respondents indicated that it would have no impact on their pharmacy.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
